Drug Profile
THR 4109
Alternative Names: Rivastigmine/venlafaxine; Sertraline/telenzepine; Telenzepine/sertraline; THR4109; Venlafaxine/rivastigmineLatest Information Update: 10 Aug 2015
Price :
$50
*
At a glance
- Originator Unknown
- Developer Theracos
- Class Obesity therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 10 Aug 2015 Discontinued - Phase-II for Obesity in Russia and Sweden (PO)